Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Dapagliflozin DPPIV Inhibitor add-on Study

ClinicalTrials.gov ID: NCT00984867

Public ClinicalTrials.gov record NCT00984867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:45 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, International Phase III Study With 24 Week Extension to Evaluate the Safety and Efficacy of Dapagliflozin 10 mg/Day in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on a DPP-4 Inhibitor Sitagliptin+/-Metformin

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metformin). The effect of dapagliflozin on weight and blood pressure will also be studied.

Study identification

NCT ID
NCT00984867
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
833 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2009 (Type not available)
Primary completion
Mar 2011 (Actual)
Completion
Sep 2011 (Actual)
Last update posted
Jun 13, 2014

2009 – 2011

United States locations

U.S. sites
45
U.S. states
21
U.S. cities
45
Facility City State ZIP Site status
Research Site Huntsville Alabama — —
Research Site Ozark Alabama — —
Research Site Anaheim California — —
Research Site Chula Vista California — —
Research Site Greenbrae California — —
Research Site Laguna Hills California — —
Research Site Los Angeles California — —
Research Site Riverside California — —
Research Site West Hills California — —
Research Site Boca Raton Florida — —
Research Site DeLand Florida — —
Research Site Jacksonville Florida — —
Research Site Longwood Florida — —
Research Site Miami Florida — —
Research Site Port Orange Florida — —
Research Site West Palm Beach Florida — —
Research Site Stone Mountain Georgia — —
Research Site Wichita Kansas — —
Research Site Lake Charles Louisiana — —
Research Site Edina Minnesota — —
Research Site St Louis Missouri — —
Research Site Las Vegas Nevada — —
Research Site Pahrump Nevada — —
Research Site Staten Island New York — —
Research Site Wilmington North Carolina — —
Research Site Cincinnati Ohio — —
Research Site Columbus Ohio — —
Research Site Dayton Ohio — —
Research Site Oklahoma City Oklahoma — —
Research Site Medord Oregon — —
Research Site Lancaster Pennsylvania — —
Research Site Philadelphia Pennsylvania — —
Research Site Mt. Pleasant South Carolina — —
Research Site Myrtle Beach South Carolina — —
Research Site Simpsonville South Carolina — —
Research Site Bristol Tennessee — —
Research Site Corpus Christi Texas — —
Research Site Dallas Texas — —
Research Site North Richland Hills Texas — —
Research Site San Antonio Texas — —
Research Site Salt Lake City Utah — —
Research Site Burke Virginia — —
Research Site Manassas Virginia — —
Research Site Richmond Virginia — —
Research Site Lakewood Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00984867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 13, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00984867 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →